Genetic variants tied to type 1 diabetes heterogeneity

November 27, 2017

(HealthDay)—Transcription factor 7 like 2 (TCF7L2) genetic variants contribute to phenotypic heterogeneity of type 1 diabetes, according to a study published online Oct. 12 in Diabetes Care.

Maria J. Redondo, M.D., Ph.D., from Texas Children's Hospital in Houston, and colleagues investigated the relationship between type 2 diabetes-associated TCF7L2 and immunologic and at type 1 diabetes diagnosis among 810 patients with newly diagnosed autoimmune type 1 diabetes (median age, 13.6 years).

The researchers found that the rs4506565 variant was a significant independent factor for expressing a single autoantibody at diagnosis, instead of multiple autoantibodies (odds ratio [OR], 1.66; P = 0.024). This association was only significant in participants ≥12 years old (OR, 2.12; P = 0.003) compared to younger ones (P = 0.73). There was a significant association between the rs4506565 variant and both higher C-peptide area under the curve (P = 0.008) and lower mean glucose area under the curve (P = 0.0127). Similar results were seen for the rs7901695 variant.

"Carriers of the TCF7L2 variant had a milder immunological and metabolic phenotype at type 1 diabetes diagnosis, which could be partly driven by type 2 diabetes-like pathogenic mechanisms," the authors write.

Explore further: Genetic data help ID risk of future impaired fasting glucose

More information: Abstract/ Full Text (subscription or payment may be required)

Related Stories

Genetic data help ID risk of future impaired fasting glucose

June 16, 2016
(HealthDay)—The addition of genetic risk variant data to conventional childhood risk factors improves risk assessment of impaired fasting glucose (IFG) and type 2 diabetes in adulthood, according to a study published online ...

Type 2 diabetes is being misdiagnosed in African-Americans, genetic study suggests

September 12, 2017
One of the tests used to diagnose type 2 diabetes and monitor blood sugar control is influenced by 60 genetic variants, an international team of scientists, including those from the Wellcome Trust Sanger Institute, has found. ...

Characteristics of diabetes in infancy explored

August 9, 2017
(HealthDay)—Diabetes in infancy has different characteristics depending on mutation subtype, and is associated with high frequency of diabetic ketoacidosis (DKA), according to a report published online Aug. 4 in Diabetes ...

Many youths with diabetes not being screened as recommended for diabetic retinopathy

March 23, 2017
Many youths with type 1 and 2 diabetes are not receiving eye examinations as recommended to monitor for diabetic retinopathy, according to a study published online by JAMA Ophthalmology.

T2DM risk cut by variant in sulfonylurea receptor encoder

April 25, 2017
(HealthDay)—A common missense variant in the gene encoding a component of the sulfonylurea receptor (ABCC8 p.A1369S), which promotes closure of the target channel of sulfonylurea therapy, mimicking the effects of therapy, ...

Serum trypsinogen levels down in type 1 diabetes

January 26, 2017
(HealthDay)—Patients with type 1 diabetes have significantly lower serum trypsinogen levels than those without type 1 diabetes, according to a study published online Jan. 23 in Diabetes Care.

Recommended for you

Team provides insight into glucagon's role in diabetic heart disease

February 21, 2018
A UT Southwestern study reveals the hormone glucagon's importance to the development of insulin resistance and cardiac dysfunction during Type 2 diabetes, presenting opportunities to develop new therapies for diabetic diseases ...

Physical exercise reduces risk of developing diabetes: study

February 20, 2018
Exercising more reduces the risk of diabetes and could see seven million fewer diabetic patients across mainland China, Hong Kong and Taiwan, according to new research.

Researchers discover link between gut and type 1 diabetes

February 19, 2018
Scientists have found that targeting micro-organisms in the gut, known as microbiota, could have the potential to help prevent type 1 diabetes.

Researchers find existing drug effective at preventing onset of type 1 diabetes

February 15, 2018
A drug commonly used to control high blood pressure may also help prevent the onset of type 1 diabetes in up to 60 percent of those at risk for the disease, according to researchers at the University of Colorado Anschutz ...

Chemist designs diabetic treatment minus harmful side effects

February 9, 2018
A chemist in the College of Arts and Sciences (A&S) has figured out how to control glucose levels in the bloodstream without the usual side effects of nausea, vomiting or malaise.

Peptide improves glucose and insulin sensitivity, lowers weight in mice

February 8, 2018
Treating obese mice with catestatin (CST), a peptide naturally occurring in the body, showed significant improvement in glucose and insulin tolerance and reduced body weight, report University of California San Diego School ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.